Project Grant R01HL177816
Award Date
9/1/24
Completion Date
6/30/28
Dollars Obligated
$131K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Texas, USA
Similar Awards
This National Science Foundation (NSF) Engineering program (CFDA 47.041) project grant award provides $347,386 to the University of Illinois to develop a novel wearable device for continuous, cuffless blood pressure (BP) monitoring. The goal is to create an accurate, inexpensive, and easy-to-use technology that can facilitate proactive management of hypertension and reduce hospitalizations related to this condition, which affects 45% of U.S. adults and is a leading risk factor for heart failure....
This $449,598 federal Project Grant award from the National Science Foundation's Engineering program (CFDA 47.041) aims to develop a novel wireless, noninvasive optical e-tattoo capable of continuously and simultaneously monitoring arterial and venous oxygenation. The key innovations include: (1) an ultrathin, stretchable e-tattoo with an array of photoplethysmography sensors over major artery-vein pairs; (2) algorithms to separate arterial and venous pulses and convert absorbance data into...
The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research Program (CFDA 93.837), awarded a $1,847,271 Project Grant to The Pennsylvania State University (Penn State) to develop a soft, stretchable, and tissue-like bioadhesive electronic device for the treatment of resistant hypertension. The 5-year project aims to create a minimally invasive device that can enable long-term, efficient, safe, and non-pharmacological neuromodulation therapies for...
This $200,000 Project Grant awarded by the National Science Foundation (NSF) Division of Electrical, Communications and Cyber Systems under CFDA 47.041 (Engineering) aims to develop and implement a novel testing platform to evaluate the accuracy of wearable photoplethysmography-based blood pressure monitoring devices. The University of Maryland, College Park will construct a bench flow phantom that simulates physiologically relevant blood pressure, blood flow, anatomical, and optical...
This Project Grant award of $267,310 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to develop an ultrasound implant to monitor spinal cord blood flow in individuals with spinal cord injury (SCI). The project aims to establish autoregulation, the ability of blood vessels to regulate organ blood flow, as a clinical marker of vascular injury following SCI. This will be achieved by quantifying...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under CFDA Program 93.837 (Cardiovascular Diseases Research) provides $488,026 to the University of Massachusetts to develop a flexible bioelectronic microarchitecture that integrates a capillary-like delivery network and a tissue-like sensing network for improving cardiac tissue engineering. The system will be integrated with cardiac microtissues to enhance tissue development and enable comprehensive analysis of...
The National Institute of Child Health and Human Development (NICHD) awarded a Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to Brigham & Women's Hospital Inc. in the amount of $237,827 to develop a wearable optical device for continuous non-invasive arterial blood pressure monitoring in neonates. The project aims to create a low-cost, wireless near-infrared spectroscopy (NIRS) device called CNAP-FLEXNIRS that can collect high-resolution...
Dynocardia Inc. received a $256,000 National Science Foundation Project Grant to advance development of a novel continuous, cuffless blood pressure monitoring device. Funded through the NSF Engineering Directorate's SBIR program, the award will support Dynocardia's efforts to address motion artifacts and enable accurate, beat-to-beat blood pressure measurements in hospital intensive care and operating room settings. Accurate 24-hour blood pressure monitoring has potential to significantly...
The National Heart, Lung, and Blood Institute (NHLBI) awarded Dynocardia, Inc. a $499,881 Project Grant under the Cardiovascular Diseases Research federal grant program (CFDA 93.837) to complete the verification and validation (V&V) of their production-grade ViTrack hospital device. ViTrack is a cuff-less, wrist-wearable device that uses proprietary optomechanical sensor and computer vision technology to provide accurate, continuous, non-invasive blood pressure monitoring for critically...
This Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $398,630.00 to the University of Alabama's Office for Sponsored Programs Division to develop an advanced, battery-free wireless sensor system for continuous monitoring of patients with chronic conditions like heart failure. The project aims to translate research on parity-time (PT) symmetric biotelemetry, inspired by non-Hermitian quantum physics, into...